USPTO serial 79292224
SYSNIB
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 20, 2021
- Examiner
- PARKS, KIMBERLY L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with SYSNIB?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,795*
Plus Government fees of $1,625
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
M. Scott Alprin
M. Scott Alprin Alprin Law Offices, P.C.5 Pinehurst Circle, N.W.Washington, DC 20015UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of cancer; drugs for medical purposes for the treatment of cancer; medicines for human purposes for the treatment of cancer; in vitro diagnostic preparations for medical purposes; diagnostic preparations for medical purposes; diagnostic test reagents for medical purposes; biochemical preparations for medical purposes for the treatment of cancer; biological reagents for medical purposes; biological preparations for medical purposes for the treatment of cancer; chemical reagents for medical purposes; reagents for medical purposes; clinical diagnostic reagents for medical purposes; diagnostic agents, preparations and substances for medical purposes; chemical preparations for medicinal purposes for the treatment of cancer; antibodies for medical purposes for the treatment of cancer; diagnostic biomarker reagents for medical purposes | ACTIVE | — |
| 009 | Laboratory apparatus and instruments for treating biological tissue for pathological studies; laboratory apparatus, instruments and their structural parts and fittings for treating biological tissue not for medical purposes; laboratory apparatus and instruments for sample pre-treatment system and sample preparation system; measuring and testing machines and instruments for genetic analysis; measuring or testing machines and instruments, namely, flow cytometers, cell-sorters, imaging cytometers, and imaging analyzers; biological cell testing apparatus for laboratory purposes; biological tissue testing apparatus for laboratory purposes | ACTIVE | — |
| 010 | Diagnostic apparatus for medical purposes for testing cancer cells, cancerous nuclei, lymphocytes, nucleoprotein, DNA, and RNA; biological cell testing apparatus for medical and medical diagnostic purposes; biological tissue testing apparatus for medical and medical diagnostic purposes; medical apparatus for clinical diagnosis of cancer; medical apparatus for pathologic diagnosis; medical apparatus and instruments for pathologic examination | ACTIVE | — |
| 042 | Genetic testing for scientific research purposes; development, testing, inspection for quality control purposes, and research of pharmaceuticals and biological preparations; testing of pharmaceuticals, inspection for quality control purposes and medical research in the fields of medical treatment method and technology; medical research; biological research; chemistry services, namely, chemistry consultation, research in the fields of biology, oncology and pathology; chemical and biological laboratory services, namely, biological, oncological and pathological research; laboratory research and analysis services in the fields of biology, oncology and pathology | ACTIVE | — |
| 044 | Clinical pathological examination and cytological diagnostics for medical purposes; medical testing for diagnostic purposes; medical testing for disease prediction; pathological examination for medical purposes and providing medical information relating thereto; genetic testing for medical purposes; medical and health services relating to DNA, genetics and genetic testing; medical services; medical information | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by NITTO BOSEKI, CO., LTD.
- Other trademarks owned by NITTO BOSEKI, CO., LTD.
- Other trademarks owned by NITTO BOSEKI, CO., LTD.
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named SYSNIB
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 20, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 7, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 5, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 5, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 17, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 17, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 20, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 20, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 4, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 4, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 2, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 14, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 14, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Apr 14, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 1, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 31, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 30, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 30, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 14, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 28, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 28, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 5, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 4, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 22, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 25, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 21, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 20, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |